EUVIMEDEUVIMED entdecken
Crossref

Characterizing juvenile-onset systemic lupus erythematosus: clinical outcomes, disease progression, and determinants in pediatric populations

Gülcan Ozomay Baykal, Betül Sözeri

ARP Rheumatology · 2026

DOI: 10.63032/flkx3464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ARP Rheumatology, 2026. Verfasst von Gülcan Ozomay Baykal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ümraniye Training and Research Hospital, Clinic of Pediatric Rheumatology. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansFemaleAdolescentMaleRetrospective StudiesDisease ProgressionChildSeverity of Illness IndexAge of OnsetImmunosuppressive AgentsChild, Preschool

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Ümraniye Training and Research Hospital, Clinic of Pediatric Rheumatology.

Zitieren

APA

Baykal, G. O., & Sözeri, B. (2026). Characterizing juvenile-onset systemic lupus erythematosus: clinical outcomes, disease progression, and determinants in pediatric populations. ARP Rheumatology. https://doi.org/10.63032/flkx3464

Vancouver

Baykal GO, Sözeri B. Characterizing juvenile-onset systemic lupus erythematosus: clinical outcomes, disease progression, and determinants in pediatric populations. ARP Rheumatology. 2026. doi:10.63032/flkx3464

BibTeX
@article{Baykal2026,
  author = {Baykal, Gülcan Ozomay and Sözeri, Betül},
  title = {Characterizing juvenile-onset systemic lupus erythematosus: clinical outcomes, disease progression, and determinants in pediatric populations},
  journal = {ARP Rheumatology},
  year = {2026},
  doi = {10.63032/flkx3464}
}
Kostenlos starten →